[Chiral drugs: pharmacological tools and/or therapeutic problems?].
Various issues connected with chiral drugs are discussed. They include definitions, the concept of stereoselectivity in pharmacodynamic and pharmacokinetic processes, the need for a stereochemically informative generic name system, and the debate surrounding eutomers versus racemates in pharmacotherapy.